Lisinopril Cost in Montana 2026: Cash Price, Medicaid, and Discount Options

What Does Lisinopril Actually Cost in Montana?

Generic lisinopril costs roughly $8 per month in cash at Montana retail pharmacies in 2026. The manufacturer list price sits near $50 per month, but almost nobody pays that figure. With a free discount coupon, the price drops to $3, $5 at chains such as Walmart, Costco, and Smith's pharmacies in Billings, Great Falls, and Missoula.

Lisinopril is one of the oldest and most widely prescribed ACE inhibitors in the United States. The original branded product Zestril lost patent protection decades ago, and the resulting generic competition pushed prices to near-commodity levels. The ALLHAT trial, which enrolled 33,357 participants and remains the largest hypertension outcomes trial ever completed, found lisinopril as effective as chlorthalidone for the primary combined cardiovascular outcome, establishing it as a guideline-recommended first-line agent. [1] Because it is so widely prescribed, retail pharmacies maintain large stock and offer competitive pricing.

A 90-day supply, which many patients prefer for convenience, typically costs $20, $25 at Walmart's $4/$10 generic program or equivalent discount programs at Costco. That works out to roughly $7 to $8 per month averaged over a quarter. Patients who call ahead to compare prices between pharmacies in smaller Montana cities such as Bozeman, Kalispell, or Helena often find the same wide range of prices that exists in larger markets. [2]

The FDA-approved prescribing information confirms lisinopril's indications for hypertension, heart failure, and left ventricular dysfunction following myocardial infarction, supporting its status as a preferred generic in most clinical settings. [3]

Does Montana Medicaid Cover Lisinopril?

Montana Medicaid does not include lisinopril on its preferred drug list without a prior authorization. Patients enrolled in Montana's Medicaid expansion program under the Affordable Care Act may obtain lisinopril, but the pharmacy must submit a prior authorization request to the Montana Department of Public Health and Human Services before dispensing. Approved requests typically allow 12-month coverage.

The prior authorization process requires documentation of a qualifying diagnosis, most commonly hypertension (ICD-10 code I10), heart failure, or chronic kidney disease (CKD). A prescribing clinician must submit clinical notes confirming the diagnosis along with the patient's current blood pressure readings or laboratory values. [4]

Physicians advising Montana Medicaid patients on hypertension management often point to the Eighth Joint National Committee (JNC 8) guideline's statement: "For the general nonblack population, including those with diabetes, initial antihypertensive treatment should include a thiazide-type diuretic, calcium channel blocker, ACE inhibitor, or ARB." [5] This guideline language supports the clinical case for prior authorization approval when clinicians document that lisinopril is medically necessary and that preferred alternatives have been tried or are contraindicated.

Patients who are denied coverage or who prefer not to manage the prior authorization process generally find the $8 cash price affordable enough to pay out of pocket, particularly with a discount coupon applied. Montana Medicaid members with both Medicare and Medicaid (dual-eligibles) may have lisinopril covered through their Medicare Part D plan instead. [6]

How Do Discount Programs and Savings Cards Work in Montana?

Free coupon programs such as GoodRx, RxSaver, and SingleCare negotiate pre-set prices with pharmacy benefit managers, and those prices apply at most Montana pharmacies. Presenting a GoodRx coupon at a Billings Walgreens or a Missoula Albertsons pharmacy typically yields a price of $3, $5 for a 30-day supply of generic lisinopril 10 mg or 20 mg. [7]

These coupons are not insurance. They are negotiated cash-pay rates. A patient using a coupon cannot also submit the same prescription to their insurance plan for that fill, because doing so constitutes insurance fraud. For most patients whose insurance deductible has not been met, the coupon price is lower than the deductible-phase cost anyway.

Manufacturer patient assistance programs exist for branded products but carry little practical relevance for generic lisinopril because the generic itself is inexpensive. The NeedyMeds database lists several programs for patients whose household income falls below 200% of the federal poverty level. A family of four in Montana qualifies at an annual income below approximately $62 to 400 in 2025 dollar terms. [8]

The American Heart Association notes that medication adherence for antihypertensive therapy is strongly associated with cost reduction interventions, and that generic substitution is among the most effective strategies for improving adherence at the population level. [9] Keeping the monthly cost at $8 or below removes a meaningful barrier for many Montana patients living in rural counties where pharmacy access is already limited.

Is Compounded Lisinopril Legal in Montana?

Compounded lisinopril is legal in Montana when prepared by a state-licensed 503A pharmacy operating under a valid prescription from a licensed prescriber. 503A pharmacies compound medications for individual patients on a patient-by-patient basis, as distinct from 503B outsourcing facilities that produce bulk compounded products. [10]

Montana's Board of Pharmacy licenses compounding pharmacies under Montana Code Annotated Title 37, Chapter 7. A 503A pharmacy in Montana may compound lisinopril in a dose, form, or concentration not commercially available, provided the final product meets USP standards for sterile or non-sterile compounding as appropriate.

The FDA's guidance on compounding makes clear that compounding pharmacies may not compound copies of commercially available products without a valid clinical rationale. Because standard lisinopril tablets are commercially available in 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg strengths, a pharmacy compounding, for example, a 7.5 mg dose or an oral suspension for a patient who cannot swallow tablets has a defensible clinical rationale. [11]

Some telehealth platforms that operate in Montana partner with 503A compounding pharmacies and offer lisinopril to eligible patients at no medication cost, covering expenses through subscription or platform fees. Patients should verify that the compounding pharmacy holds an active Montana license before accepting a compounded prescription. The Montana Board of Pharmacy's online license verification tool is publicly accessible.

Can Montana Patients Get Lisinopril via Telehealth?

Telehealth prescribing of lisinopril is fully legal in Montana in 2026. Montana law permits prescribing after a valid patient-provider relationship is established via synchronous audio-visual telehealth. No in-person visit is required for a new hypertension prescription under current Montana statute, provided the clinician performs an adequate history and review of available clinical data. [12]

Several national telehealth platforms hold Montana medical licenses and can prescribe lisinopril to Montana residents. A typical telehealth visit for hypertension management costs $40, $75 without insurance, though many major insurers now cover telehealth visits at the same rate as in-person primary care. [13]

Patients initiating lisinopril via telehealth should be prepared to provide home blood pressure readings, a list of current medications, and any recent laboratory results including serum creatinine and potassium, because ACE inhibitor therapy requires baseline and follow-up monitoring of renal function and electrolytes per American College of Cardiology and American Heart Association guidelines. [14]

The 2023 AHA/ACC guideline on hypertension specifies that a target blood pressure of <130/80 mm Hg is appropriate for most adults, reinforcing why initiating lisinopril promptly through whatever prescribing channel is accessible matters for long-term cardiovascular risk reduction. [15]

Which Insurance Plans Cover Lisinopril in Montana?

Most private insurance plans operating in Montana in 2026 place generic lisinopril on Tier 1 (preferred generic), meaning the patient copay is typically $0, $10 per 30-day fill after the deductible is met. Montana's federally facilitated marketplace plans through Healthcare.gov must cover essential health benefits including prescription drugs, and generic lisinopril appears on virtually every formulary. [16]

Employer-sponsored plans in Montana, covering roughly 51% of non-elderly residents per Kaiser Family Foundation state health facts, uniformly list lisinopril as a Tier 1 generic. The typical Tier 1 copay in Montana employer plans runs $5, $10 per fill. [17]

Medicare Part D plans available in Montana vary in their formulary placement. Lisinopril appears on 96% of Part D formularies nationally. In Montana, Part D enrollees whose plan places lisinopril on Tier 1 pay $0 during the coverage phase after meeting the plan deductible (capped at $590 in 2026). Those on Tier 2 pay $10, $20. Medicare beneficiaries can compare plans at Medicare.gov's plan finder tool using their zip code and current prescriptions. [18]

Patients on high-deductible health plans (HDHPs) in Montana face the full negotiated price until they meet their deductible, which averaged $1,735 for single coverage in 2024 per KFF data. For those patients, a GoodRx coupon producing a $4 fill is almost always less expensive than running the prescription through insurance during the deductible phase. [19]

What Is the Cheapest Way to Get Lisinopril in Montana?

The cheapest reliable route for most Montana residents in 2026 is a GoodRx or RxSaver coupon applied at Walmart, Costco, or a warehouse pharmacy, yielding a price of $3, $5 for a 30-day supply. A 90-day supply via Walmart's $10 generic program brings the per-month cost closer to $3.33. [7]

Patients without easy pharmacy access who live in rural Montana counties, such as Petroleum County (population under 500) or Garfield County, may find mail-order pharmacy services more practical. Most major Part D plans include a mail-order benefit that delivers a 90-day supply for the cost of two copays, effectively providing one fill free per quarter. [18]

For patients with very low income, the federal Extra Help (Low Income Subsidy) program through the Social Security Administration reduces Medicare Part D drug costs to a nominal amount, often $0 or $1.45, $4.50 per prescription depending on the income tier. Montana residents can apply for Extra Help through SSA.gov or through their local Montana Department of Public Health and Human Services office. [20]

The HealthRX Montana Lisinopril Cost Decision Framework works as follows. First, check whether your plan places lisinopril on Tier 1. If yes and your deductible is met, use your insurance. If your deductible is not yet met or you are uninsured, compare the GoodRx price at the two nearest pharmacies. If the GoodRx price exceeds $10, apply through NeedyMeds or Extra Help. If you are a Montana Medicaid enrollee, ask your prescriber to submit a prior authorization, because an approved PA makes lisinopril a $0 fill. Telehealth visits are appropriate for initiating or continuing therapy if no local prescriber is available within a reasonable drive.

How Does Lisinopril's Clinical Evidence Support Its Use?

Lisinopril's evidence base is among the strongest of any antihypertensive drug class. The ALLHAT trial (N=33,357) published in JAMA 2002 compared lisinopril with chlorthalidone and amlodipine. The primary combined outcome of fatal coronary heart disease or nonfatal MI did not differ significantly across the three arms, with a relative risk of 0.99 (95% CI 0.91, 1.08) for lisinopril versus chlorthalidone. [1]

The GISEN Group's REIN trial showed that ramipril, a related ACE inhibitor, significantly slowed GFR decline in patients with non-diabetic proteinuric CKD. [21] This class-level evidence underpins guideline recommendations from the American Diabetes Association that ACE inhibitors remain first-line therapy for patients with diabetes and hypertension who have elevated urinary albumin-to-creatinine ratios above 30 mg/g. [22]

For heart failure with reduced ejection fraction (HFrEF), lisinopril's evidence includes the ATLAS trial (N=3,164), which compared low-dose (2.5 to 5 mg/day) versus high-dose (32.5 to 35 mg/day) lisinopril and found that high-dose therapy reduced the combined risk of death or hospitalization by 12% (P<0.002). [23]

Dr. Paul Whelton, lead author of the 2017 ACC/AHA Hypertension Guidelines, stated in the guideline document: "The benefits of treating hypertension to lower blood pressure goals are well established across multiple drug classes including ACE inhibitors, and the choice of agent should account for comorbidities, tolerability, and cost." [15] Generic lisinopril satisfies all three criteria for most Montana patients.

The FDA-approved label for lisinopril specifies monitoring of serum creatinine and potassium within 2 to 4 weeks of initiation or dose change, particularly in patients with baseline CKD or those taking potassium-sparing diuretics or potassium supplements. [3] An estimated 10 to 15% of patients develop a dry, persistent cough attributable to bradykinin accumulation, which may prompt a switch to an ARB such as losartan. [24]

Monitoring Requirements and Safety Considerations

ACE inhibitor therapy requires baseline and periodic laboratory monitoring. Standard practice per AHA/ACC guidance calls for a basic metabolic panel, including serum creatinine, BUN, sodium, and potassium, before starting lisinopril and again at 2 to 4 weeks after initiation. [14] Thereafter, annual monitoring is appropriate for stable patients without CKD; those with CKD stage 3b or worse (eGFR <45 mL/min/1.73 m2) need monitoring every 3 to 6 months. [25]

Lisinopril carries an FDA boxed warning for fetal toxicity. Women of childbearing potential must use effective contraception while taking the drug, and the medication must be discontinued as soon as pregnancy is detected. [3]

Angioedema, though rare at an incidence of approximately 0.1 to 0.7% in most surveillance datasets, can be life-threatening. Black patients have a 2, 4-fold higher incidence of ACE inhibitor-associated angioedema compared with white patients, a finding replicated in a pharmacovigilance analysis of over 2 million prescriptions. [26] Patients experiencing facial swelling, lip swelling, or throat tightness must discontinue lisinopril immediately and seek emergency care.

Drug interactions of clinical significance in Montana's patient population include concurrent use of NSAIDs (common given the region's active outdoor culture and musculoskeletal injury rate), which may blunt antihypertensive effect and accelerate renal function decline. [27] Combining lisinopril with aliskiren is contraindicated in patients with diabetes. [3]